Study protocol: phase II study to evaluate the effect of cetuximab monotherapy after immunotherapy with PD-1 inhibitors in patients with head and neck squamous cell cancer
研究方案:一项II期研究,旨在评估西妥昔单抗单药治疗在接受PD-1抑制剂免疫治疗的头颈部鳞状细胞癌患者中的疗效。
期刊:Therapeutic Advances in Medical Oncology
影响因子:4.2
doi:10.1177/17588359231217959
Burcher, Kimberly M; Bloomer, Chance H; Gavrila, Elena; Kalada, John M; Chang, Mark J; Gebeyehu, Rediet R; Song, Alexander H; Khoury, Lara M; Lycan, Thomas W; Kinney, Rebecca; D'Agostino, Ralph Jr; Bunch, Paul M; Shukla, Kirtikar; Triozzi, Pierre; Furdui, Cristina M; Zhang, Wei; Porosnicu, Mercedes